PF 477736
Alternative Names: PF-00477736; PF-477736; PF-736Latest Information Update: 12 Apr 2011
Price :
$50 *
At a glance
- Originator Pfizer
- Class Antineoplastics; Benzodiazepinones; Pyrazoles; Small molecules
- Mechanism of Action Checkpoint kinase 1 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Solid tumours
Most Recent Events
- 06 Apr 2011 Pharmacodynamics data from a preclinical trial in Solid tumours presented at the 102nd Annual Meeting of the American Association for Cancer Research (102nd-AACR-2011)
- 27 Sep 2010 Discontinued - Phase-I for Solid tumours in Australia (IV)
- 27 Sep 2010 Discontinued - Phase-I for Solid tumours in USA (IV)